The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 APP Pharmaceuticals  (APPX) Trade Now »     Rate APPX  -  Discuss APPX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate APPX:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

APPX: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

APP Pharmaceuticals Graphic_rating_buy APPX
Foto
62%

APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading provider of hospital-based injectable pharmaceutical products, and Fresenius SE (XETRA:FRE), a global health care group with approximately $18B of sales in products and services for hospital, dialysis and in home medical care, today announced that they have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP.

<> Under the terms of the agreement, Fresenius will acquire the outstanding common stock of APP for $23.00 in cash per share (the "Cash Purchase Price") plus a contingent value right ("CVR") that ...
By  Marian Filo   (-24.55%  risk: aggressive)  07/08/08 Comment




From the Blogosphere

An Overview and Analysis of the Global Generic Drug Industry
Mikerun
73%
Global Generic Drug Index Stats
<> Top 5 Companies by Market Cap
Top 5 Companies by 52-Week Stock Price Change
<>


The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity -- including the following buyout offers:

Industry leader Teva Pharma (TEVA): buyout bids for Barr (BRL) ($7.5B) & Bentley Pharma (BNT) ($350M)

Sanofi-Aventis (SNY): a $2B bid for Czech-based Zentiva
Daiichi-Sankyo (Tokyo: 4568): a $4.6B bid for India-based Ranbaxy (500359)
<>
Fresenius Medical (FMS): buyot of generic injectable firm ...
By  Mike Havrilla   (+1.04%  risk: conservative)  10/11/08 Comment


Pre-Open Movers 7/7: APP Pharmaceuticals (APPX) Up on Buyout; Marshall & Ilsley (MI) Lower After Predicting Large Q2 Loss

StreetInsider.com Pre-Open Movers:

<>APP Pharmaceuticals, Inc. (Nasdaq: APPX) 33.8% HIGHER; and Fresenius SE (XETRA: FRE) entered into a definitive merger agreement pursuant to which Fresenius will acquire APP. Under the terms of the agreement, Fresenius will acquire the outstanding common stock of APP for $23.00 in cash per share plus a contingent value right that could deliver up to an additional $970 million, or $6.00 per share in cash, if the financial results of the Company meet certain targets. APP Pharmaceuticals closed at $17.82 on Friday.

Marshall & Ilsley Corporation (NYSE: MI) 12% L...
By  Street Insider   (+16.23%  risk: moderate)  07/07/08 Comment


Saying a lot in very few words…

Earlier today, Fresenius SE (FRE3:GY) announced that it was buying APP Pharmaceuticals (APPX) for $4.6 billion, or around $23 a share. The deal represented a substantial premium — just shy of 30% — over where APP’s shares closed on Thursday, before the markets closed for the July 4 holiday.

<>But what’s really interesting is this 8K that the company filed around 2:30 pm on July 3. There’s very few words here — far fewer than I normally like to see when trying to spot these sorts of things in advance. And because the actual agreements weren’t included, it made it even more difficult to <><>< />< /><><><><>< /><><>< /><>< /><>< /><>< />< />...
By  footnoted   (+0.00%)  07/07/08 Comment


Fresenius gets some APP medicine for $3.7 billion

Filed under: Deals

It's been a good year for APP Pharmaceuticals Inc. (NASDAQ: APPX), as the stock price has climbed from $10 to $23.50. Today there was some extra good news: Fresenius SE, the largest intravenous drug developer in Europe, has agreed to shell out $3.7 billion for the company (there will also be $940 million in assumed debt). In today's trading, APP's stock is up 32%.

It's a great day for Soon-Shiong who founded APP in 1996 and still owns a whopping 80% of the company.

<>APP is a leader in developing generic injectable pharma products, such as for acute care and specialty clinic a...
By  Tom Taulli   (+0.00%)  07/07/08 Comment


Before the bell: MER, APPX, AAPL, MRK, DIS, NWS

Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Deals, Apple Inc (AAPL), Walt Disney (DIS), Merrill Lynch (MER), Merck and Co (MRK), News Corp'B' (NWS)

Before the bell: Futures mixed as oil drops, ahead of earnings season kickoff

According to the New York Post Friday, Merrill Lynch (NYSE: MER) is in talks to sell its 20% stake in Bloomberg L.P. back to New York City Mayor Michael Bloomberg. The post cited anonymous sources. But Merrill will likely not end its cash raising efforts there and could also try to sell its 49% stake in investment manager BlackRock (NY...
By  Melly Alazraki   (+6.38%  risk: moderate)  07/07/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.23% 368
2 Gerald Greene 18.14 +70.19% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 60
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
SIRI Sirius Satellite Radio Inc
GOOG Google Inc
FRE Freddie Mac
EBAY eBay Inc
F Ford Motor Company
ETFC E*Trade Financial Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on APPX

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About APP Pharmaceuticals - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch